Malin Grönberg
Researcher at Institutionen för medicinska vetenskaper; Onkologisk endokrinologi
- Telephone:
- +46 18 471 47 11, +46 18 471 47 14
- E-mail:
- Malin.Gronberg@medsci.uu.se
- Visiting address:
- Rudbecklaboratoriet, R3, vån 2
SE-75185 Uppsala
Sweden - Postal address:
- Rudbecklaboratoriet, R3, vån 2
SE-75185 Uppsala
Sweden
- ORCID:
- 0000-0003-4001-0572
More information is available to staff who log in.
Short presentation
This text is not available in English, therefore the Swedish version is shown.
Keywords
- cancer
- ghrelin
- hormon
- neuroendocrine cancer
- peptides
- research
Biography
My basic education is a M.Sc. in Biotechnology from SLU/Uppsala University.
I performed my Ph.D. in the field of Medical sciences at Uppsala University.
Research
Research concerning the expression and function of different peptide hormones in normal and neoplastic tissue.
Publications
Recent publications
- Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy (2024)
- Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort (2023)
- Adrenalectomy in ectopic Cushing's syndrome (2021)
- Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2 (2021)
- PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 (2020)
All publications
Articles
- Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy (2024)
- Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort (2023)
- Adrenalectomy in ectopic Cushing's syndrome (2021)
- Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2 (2021)
- PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3 (2020)
- Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3 (2020)
- Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome (2020)
- Intravenous versus Oral Etoposide (2018)
- Intravenous versus oral etoposide (2018)
- Ghrelin expression is associated with a favorable outcome in male breast cancer (2018)
- Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma (2017)
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors (2017)
- Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer (2017)
- Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3) (2016)
- Ghrelin and Obestatin in Human Neuroendocrine Tumors (2013)
- Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer (2012)
- Neuroendocrine markers are expressed in human mammary glands (2010)
- Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays (2009)
- Distribution of obestatin and ghrelin in human tissues (2008)
- Somatostatin induces rapid contraction of neuroendocrine cells (2007)
- Expression of ghrelin is correlated to good outcome in invasive breast cancer
- Expression of ghrelin and obestatin in neuroendocrine tumors